Sullivan & Cromwell’s cohesive Greater China practice provides a ‘very efficient and knowledgeable’ service across US, Hong Kong and English law, pertinent to international, Chinese and regional clients seeking to execute a variety of equity transactions – from IPOs, follow-on and secondary offerings to equity-linked securities and equity derivatives. The team, which is co-headed by Kay Ian NG and Ching-Yang Lin, is particularly effective at advising banks as underwriters/sponsors and has been active of late on Hong Kong IPOs/global offerings relating to Chinese tech and healthcare companies. The team also has niche expertise advising on Taiwanese deals, including in the context of GDS offerings.
Testimonials
Collated independently by Legal 500 research team.
- 'The team is very efficient and knowledgeable.'
Key clients
- Taiwan Cement Corporation
Work highlights
- Advised the underwriters in Sichuan Kelun-Biotech Biopharmaceutical’s IPO and listing on The Stock Exchange of Hong Kong.
- Advised the underwriters in relation to LianLian DigiTech Co's global offering and listing on The Stock Exchange of Hong Kong.